Basel Area Life-Science Ecosystem – Handelszeitung
Basel, May 15, 2025: See Anaveon’s contribution to the Handelszeitung special report on the status of Life Sciences in Basel: Handelszeitung
Latest News
21.05.2025
Anaveon announces presentation of a trial in progress poster to be presented at the American Society for Clinical Oncology 2025 Annual Meeting on Monday, June 2, 2025 in Chicago
– EXPAND-1 is a clinical study with ANV600, a novel PD-1 targeted IL-2R-βγ agonist, in monotherapy and in combination with pembrolizumab in cancer patients – Basel, May 21, 2025 – Anaveon, a clinical stage, immuno-oncology company, today announced that it will present a poster on…Read more
19.05.2025
Basel Area Life-Science Ecosystem – Handelszeitung
Basel, May 15, 2025: See Anaveon’s contribution to the Handelszeitung special report on the status of Life Sciences in Basel: HandelszeitungRead more
01.04.2025
Immuno-Oncology Progress: PragmaTIL Trial Receives Approval, with Anaveon as a Key Partner
As a key partner, we are proud to announce that PragmaTIL has received regulatory approval to launch its clinical trial, bringing safer and more effective cell therapy one step closer to cancer patients. 🔬 The trial will start at VHIO (Spain) and Herlev Hospital (Denmark),…Read more
Corporate Positioning & Design, Concept, Webdesign & Code:
Schlatter corporate GmbH
Davidstrasse 45
CH-9000 St.Gallen
schlattercorporate.com
Schlatter corporate GmbH
Davidstrasse 45
CH-9000 St.Gallen
schlattercorporate.com